Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 18, 2014 11:00 ET | Source: Levolta Pharmaceuticals, Inc.

Levolta Pharmaceuticals Presents Phase II Study Results for Potential Osteoarthritis Therapy at ACR Annual Meeting

BETHLEHEM, Pa., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Levolta Pharmaceuticals, Inc. today presented the results of an exploratory Phase II study for a potential disease modifying drug for patients with...